Cargando…
Metal–Phenolic Network-Facilitated “Foe-to-Friend” Conversion of Melittin for Cancer Immunotherapy with Boosted Abscopal Effect
As a naturally occurring cytolytic peptide, melittin (Mel) has strong cytolytic activity and is a potent therapeutic peptide for cancer therapy. However, the serious hemolytic activity of Mel largely impedes its clinical applications. In this work, based on the strong interactions between proteins/p...
Autores principales: | Guo, Yuxin, Zhang, Xinping, Wang, Shao-Zhe, Feng, Hui-Heng, Wu, Shun-Yu, Wu, Fu-Gen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AAAS
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10013787/ https://www.ncbi.nlm.nih.gov/pubmed/36930774 http://dx.doi.org/10.34133/research.0052 |
Ejemplares similares
-
Antibiotics and immunotherapy in gastrointestinal tumors: Friend or foe?
por: Yan, Cong, et al.
Publicado: (2019) -
Ferroptosis: friend or foe in cancer immunotherapy?
por: Demuynck, Robin, et al.
Publicado: (2023) -
Friend or Foe: Prognostic and Immunotherapy Roles of BTLA in Colorectal Cancer
por: Song, Jingjing, et al.
Publicado: (2020) -
Interleukin-21 in cancer immunotherapy: Friend or foe?
por: Stolfi, Carmine, et al.
Publicado: (2012) -
Adrenergic Signaling in Immunotherapy of Cancer: Friend or Foe?
por: Jensen, Agnete Witness Praest, et al.
Publicado: (2021)